SANDS CAPITAL LIFE SCIENCES PULSE FUND II, L.P. enters INHIBIKASE THERAPEUTICS, INC. with 10.95M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 10/25/2024ACC: 0000950170-24-117493
→
10% Owner
Since Oct 2024
10.95M
Baseline shares
100% direct
10.95M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned10.95M
Total
10.95M direct10.95M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.95M | Direct |
| Total | 10.95M | 10.95M direct |
Derivative Holdings0
No derivative holdings reported